Markus Haindl

Markus Haindl

Company: Roche

Job title: Head Gene Therapy Technical Development


Considerations Towards Development of In Vivo Gene Therapies – a Risk Based Approach 8:15 am

In vivo Gene Therapy: key principles and major cmc challenges Understanding the linkage between CMC and clinical outcomesRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.